Trials / Unknown
UnknownNCT05596643
Investigation of Autonomic Dysfunction in Patients With Familial Mediterranean Fever
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Marmara University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Familial Mediterranean Fever (FMF) is the most common inherited autoinflammatory disease affecting 150,000 patients worldwide. Periodic febrile exacerbations, peritonitis, and pleuritis are characteristic disease features. Dysregulation of IL-1β secretion has an important role in the pathophysiology of the disease, and IL-1β also serves as a therapeutic target. Chronic inflammation has been associated with early atherosclerotic and cardiovascular disease in various rheumatic diseases. An increased risk for cardiovascular events associated with disease activity has been described in rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. In addition, autonomic nervous system dysfunction may contribute to increased cardiovascular risk in patients with inflammatory disease. For example, decreased heart rate variability is an important feature of cardiac autonomic dysfunction and is an isolated risk factor for cardiovascular events. Autonomic dysfunction studies related to FMF have conflicting results. The aim of this study was to determine autonomic dysfunction symptoms and objective findings in patients with FMF; Demographic characteristics, disease characteristics, inflammatory burden, fatigue level, sleep quality, presence of fibromyalgia and their relationship with quality of life were evaluated and compared with healthy controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Composite Autonomic Symptom Score-31 | Standardized questionnaire to determine the level of autonomic dysfunction |
| DIAGNOSTIC_TEST | r-r interval variability with normal breathing | electrophysiological test to detect parasympathetic dysfunction |
| DIAGNOSTIC_TEST | r-r interval variability with deep breathing | electrophysiological test to detect parasympathetic dysfunction |
| DIAGNOSTIC_TEST | Valsalva ratio | electrophysiological test to detect parasympathetic dysfunction |
| DIAGNOSTIC_TEST | 30:15 ratio | electrophysiological test to detect parasympathetic dysfunction |
| DIAGNOSTIC_TEST | sympathetic skin response | electrophysiological test to detect sympathetic dysfunction |
| DIAGNOSTIC_TEST | blood pressure response to standing | clinical test to detect sympathetic dysfunction |
| DIAGNOSTIC_TEST | blood pressure response to sustained handgrip test | clinical test to detect sympathetic dysfunction |
| OTHER | Hospital anxiety and depression scale | Standardized questionnaire to investigate the depression and anxiety |
| DIAGNOSTIC_TEST | Fibromyalgia rapid screening tool | Standardized questionnaire to determine the presence of fibromyalgia |
| OTHER | Familial Mediterranean Fever Quality of life scale | Standardized questionnaire to investigate the quality of life in Familial Mediterranean Fever patients |
| OTHER | Jenkins Sleep Evaluation Scale | Standardized questionnaire to investigate the sleep quality and disturbance |
| OTHER | The Fatigue Severity Scale | Standardized questionnaire to investigate the fatigue severity |
Timeline
- Start date
- 2022-03-15
- Primary completion
- 2022-10-31
- Completion
- 2022-10-31
- First posted
- 2022-10-27
- Last updated
- 2022-10-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05596643. Inclusion in this directory is not an endorsement.